Accelerate Diagnostics Inc. (NASDAQ:AXDX) went down by -7.36% during the previous trading session, and it is maintaining the win ahead of Thursday’s trading session. The share price of the Diagnostics & Research giant went up by $15.86 to trade ended Thursday trading at $17.12. This is down from the $17.12 price recorded on Wednesday’s trading session. Thanks to this latest performance, AXDX is closer to the higher price 52-week target of $14.00 and further from the lowest price target of $12.00. Its performance from the start of the year has also been negative, with AXDX down by -6.15% year-to-date.
Accelerate Diagnostics Inc. (AXDX) started the day trading at $17.51 and recorded an intraday high of $18.54. It also recorded an intraday low of $15.12 during Thursday’s trading session. Accelerate Diagnostics Inc. is a very active stock that recorded a trading volume that is more than 52.15% of the average daily trading volume on Thursday. The stock’s trading volume on Thursday was 1033500, which is more than 52.15 of the total average daily trading volume of 494.57K.
Accelerate Diagnostics Inc. (NASDAQ:AXDX) 2020 Performance Impressive
The increase in AXDX’s stock price on Thursday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of AXDX currently stands at $24.00, which is higher than the current trading price of the stock by 33.92%. However, AXDX’s current trading price is -250.11% lower than the 52-week low price of $4.53. In terms of trading volume, Accelerate Diagnostics Inc. currently experienced healthy participation during the last trading session. 1033500 shares of Accelerate Diagnostics Inc. were traded on the stock exchange on Thursday, which is more than 52.15% of the 494.57K average trading volume of the stock.
The performance of the stock has been positive over the past year. AXDX’s performance over the past one year has seen it plunge by -33.70%, while the stock has gone down by -6.82% in the last six months. The quarterly performance of AXDX currently stands at 109.79%, and it is up by 93.18% in the last month. The only positive figure was from the weekly performance, which currently reads 23.04%. At the time of writing AXDX’s report, the company has a total market cap of $794.90M, making it one of the largest publicly-traded companies in the world.Accelerate Diagnostics Inc. also has over 275 employees all over the world.
AXDX Insider Activities
For Accelerate Diagnostics Inc., insiders hold 55.40% of all company shares. The insider transactions over the past six months are up by 24.30%. During that period, insiders bought 3,308,496 shares in 38 transactions. In that same period, insiders sold 1,109,000 of their shares in 4 transactions. After these transactions, insiders at Accelerate Diagnostics Inc. now hold 22.47M shares, which is over 53.53% of the total company stocks. Institutional investors currently hold a large chunk of the AXDX shares, as they control 40.66% of the company’s total stock.
AXDX Fundamental Analysis
For Accelerate Diagnostics Inc., the stock’s diluted earnings per share (EPS) stands at -1.54. In the coming year, analysts expect the EPS to be -1.11. The EPS growth will up over the next five years to 30.00% after plunging by -16.90% in the previous five years. In terms of revenue, Accelerate Diagnostics Inc.’s quarterly sales (YOY) is shrinking at -0.34, which is higher than the average annual revenue of -16.90% over the past half a decade.
The Return on Investment (ROI) on Accelerate Diagnostics Inc.’s stock currently stands at -59.30%. The gross margin of the company is 46.70%.
AXDX Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of AXDX currently stands at 36.24%, while the SMA50 is 53.29%. The biggest one is the SMA200, which is currently reading 14.34% ahead of Thursday’s trading session. The Relative Strength Index of this stock is 72.55.